I.Market and Financial News
1.Pharmaceutical Stocks Rise:Investor demand increases due to strong R&D progress and positive trial results in diabetes and obesity treatments.(ID:18189058)
2.Indian Pharma Expands in Kazakhstan:Talks between health officials focus on increasing cooperation and registration of Indian drugs and medical devices.(ID:18133782)
3.Pharma ETF Trading Volume Up:iShares U.S. Pharmaceuticals ETF sees a 30% increase in trading volume, driven by institutional buying.(ID:18108178)
4.Wells Fargo Maintains Avadel Rating:Analysts forecast a 6.09% upside for Avadel Pharmaceuticals, with increased institutional ownership.(ID:18152158)
5.Truist Recommends Collegium Buy:Analysts maintain a buy rating with an 11.88% upside forecast for Collegium Pharmaceutical.(ID:18110107)
6.Weight Loss Drug Prices Lowered:Novo Nordisk and Eli Lilly agree to reduce prices for Medicare and Medicaid patients, securing tariff exemptions.(ID:18069274)
7.Russia Drug Prices Increase:Experts attribute price hikes to import dependency and inflation, particularly affecting cold medicines.(ID:18029454)
II.Regulatory and Policy Updates
1.French Senate Proposes EU Drug Plan:Calls for a more ambitious European plan to address drug shortages, including reimbursement clauses for undelivered medications.(ID:18136468)
2.EU Advocate for Drug Access:Emphasis on healthcare as a right and the need for price transparency and competition in the European drug market.(ID:18135498)
3.France Mandates Drug Price Disclosure:National Assembly requires public disclosure of actual drug prices and discounts to ensure democratic oversight of healthcare spending.(ID:18135738)
4.India Cracks Down on Illegal Drug Sales:Police raids reveal unregulated sale of sedatives without prescriptions, prompting citywide enforcement actions.(ID:18133581)
5.India’s Drug Pricing System Flawed:Study reveals systemic issues in pricing, with many critical medicines for rare diseases remaining unaffordable despite caps.(ID:18115321)
6.Italy Pharma Seeks Payback Reform:Industry leaders demand structural government interventions to address payback concerns and ensure sustainability.(ID:18059227)
III.Manufacturing and Supply Chain
1.EuroApi Manufacturing Strike:Workers strike against restructuring plans that could reduce production by 40% annually and lead to job losses.(ID:18187253)
2.German Antibiotic Import Reliance:Germany’s strategy to source antibiotics from Europe fails, with most orders still going to Asian suppliers.(ID:18154382)
3.Italy Oncological Drug Shortages:Alleged shortages prompt complaints and investigations into supply chain issues for cancer treatments.(ID:18197270)
4.Mexico Achieves 99% Medicine Procurement:Government reports high procurement rates with significant savings, ensuring supply for public health.(ID:18150156)
5.Russia Inspects Kidney Drug Supply:Regulatory bodies probe shortages of essential drugs for kidney disease patients in multiple regions.(ID:18112378)
IV.Research and Development
1.Long-Term Meds Deplete Vitamins:Doctors warn that prolonged medication use can lead to vitamin deficiencies, increasing fatigue and weakening immunity.(ID:18201571)
2.India Extends Pharma R&D Deadline:Government extends application deadline for a ₹5,000 crore scheme to boost research infrastructure and industry grants.(ID:18096773)
3.Turkey Expands Cancer Drug Coverage:Social Security Institution covers five immunotherapy drugs, benefiting thousands of patients with various cancer types.(ID:18149180)
Disclaimer: This is a curated digest of industry news from public sources. The information is for general insight and is not professional advice; readers should verify details independently. Please provide news ID when you need the original url.
PHARMACEUTICAL INDUSTRY PULSE
